Showing results (41-50 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|November 7, 2019
Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studiesManuel Anguita, Mariano de la Figuera, Alejandro I Pérez Cabeza, et al.Drugs in Context|December 18, 2019
Drug therapy for double-hit lymphomaVania Phuoc, Jose Sandoval-Sus, Julio C ChavezDrugs in Context|March 24, 2020
Management of psoriasis in pregnancy - a review of the evidence to dateClara Ferreira, Alexandra Azevedo, Miguel Nogueira, et al.Drugs in Context|March 12, 2020
Clinical use of Capilen, a liposomal cream based on fresh plant extracts enriched with omega fatty acidsLuca Giacomelli, Alessandra Moglia, Gianedoardo Losa, et al.Drugs in Context|March 12, 2020
Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experienceFelicia Pantò, Liboria Adamo, Carla Giordano, et al.Drugs in Context|February 6, 2019
Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USAAlpesh Amin, W Richey Neuman, Melissa Lingohr-Smith, et al.Drugs in Context|March 15, 2018
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study)Ignacio Marín-Jiménez, Cristina Saro, Verónica Díaz, et al.Drugs in Context|September 1, 2020
Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United StatesArpita Nag, Rebecca Bornheimer, Gerry OsterDrugs in Context|April 8, 2020
HIV, drugs and the kidneyNicola Wearne, Bianca Davidson, Marc Blockman, et al.Drugs in Context|April 8, 2020
Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment managementAntonio Ruggiero, Palma Maurizi, Silvia Triarico, et al.Pageof 56